Eastman Kodak

Real-time Quotes | Nasdaq Last Sale

Opening 15:39 10/29 EDT
Corp Actions
Stay Away From Kodak Stock Until Its Hobby Is a Business
Kodak (NYSE:KODK) is pledging to move ahead with making Active Pharmaceutical Ingredients (APIs) for generic drugs, even though the company has not received assurances that it will obtain government funding for that business. Unfortunately for the company, investors don’t seem to be enthused about the venture; as of this writing, Kodak stock is down 17% over the last 30 days. Source: Katherine Welles / To recap, this summer Kodak submitted a “letter of interest” for a $765 million loan that would enable the company to manufacture APIs for generic drugs. Kodak stock, which was long left for dead, soared on the news. However, Kodak immediately was hit by allegations of   insider trading.InvestorPlace - Stock Market News, Stock Advice & Trading Tips But there’s a bigger problem with this narrative. As investors begin to digest the actual substance of the news, the story doesn’t get better. Kodak has institutional knowledge of chemical manufacturing. But pharmaceutical manufacturing? Not so much. And that makes me wonder if Kodak is committed to this latest venture or if it’s just a hobby that may lead to the company making an acquisition. Either way, I can’t recommend the stock, but I’ll let you decide. 7 Airline Stocks to Buy on Pelosi Stimulus Hopes Globalism Versus Nationalism To understand why the U.S. government offered Kodak this opportunity in the first place, you have to consider the current national debate between globalism and nationalism. Since the 1980s, the United States has been outsourcing American jobs to cheaper, overseas markets. As a result, the U.S. became heavily dependent on these nations for our energy, other commodities, many manufacturing goods, etc. President Donald Trump, for better or worse, took a wrecking ball to globalism. Even before the pandemic, the Trump administration had been focusing on bringing supply chains back to America. According to the nationalists, this is a matter of national security as well as a benefit to the economy. Can Kodak Make America Great Again? With that as a backdrop, the Kodak deal at least makes a smidgen of sense. For years,  generic drugs have been produced offshore. The reality is that many of the major manufacturers of U.S. generic drugs  are not wholly located in America. For example, Teva Pharmaceuticals (NYSE:TEVA) has dual headquarters in Israel and the U.S. The same is true for Mylan (NASDAQ:MYL) which has offices in the United Kingdom and the Netherlands, as well as a “global center” in Pennsylvania. From a 50,000-foot view, this seems to be the reason that Kodak was considered for this loan. Trump and White House Trade Director Peter Navarro made a point to refer to Kodak as a great American company. And the Wall Street Journal recently confirmed at least the broad outline of this line of reasoning. “Trump administration officials said the Kodak alliance would help expedite domestic production of drugs that can treat a variety of medical conditions and loosen U.S. reliance on foreign sources in countries such as China and India.” Of course, this also means that the loan will not be approved if Trump is defeated. In fact, Kodak said as much  when it unveiled its “Letter of Interest” (LOI) for the loan. To be clear, Kodak does have limited experience as a chemical manufacturer. But that doesn’t necessarily translate into the company manufacturing pharmaceuticals  on a large scale. The Bottom Line on Kodak Stock Were you one of the investors who jumped on Kodak stock at the end of July? If so, congratulations, you’re sitting on a gain of nearly 400%. And that’s why it may be time to sell the shares before you commit the cardinal sin of losing your gains. Kodak is attempting to reinvent itself by breaking into a business in which it has little experience. And it’s a field that’s well-established with several significant players, including a number in the U.S. Nevertheless, the re-election of Trump would go a long way towards ensuring that the company does receive the $765 million dollar loan. Otherwise, I don’t think there’s a good chance of this deal being  finalized. And without that funding, it appears that Kodak has a hobby, not a business. And I don’t believe in making investments based on hobbies. On the date of publication Chris Markoch did not have (either directly or indirectly) any positions in the securities mentioned in this article. Chris Markoch is a freelance financial copywriter who has been covering the market for over six years. He has been writing for InvestorPlace since 2019. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG Top Stock Picker Reveals His Next 1,000% Winner Radical New Battery Could Dismantle Oil Markets Revolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 Company The post Stay Away From Kodak Stock Until Its Hobby Is a Business appeared first on InvestorPlace.
InvestorPlace · 6d ago
Despite 2020’s Wild Ride, Kodak May Have More Downside Ahead
InvestorPlace · 10/21 20:38
Kodak CEO Says Moving Forward On Generic Drug Ingredients Venture, With or Without Federal Loan
Eastman Kodak Co (NYSE: KODK) CEO Jim Continenza said Monday that the company would push ahead with making generic drug ingredients, irrespective of whether it receives government assistance or not, the Wall Street Journal
Benzinga · 10/20 01:19
Kodak CEO Says Company Will Still Work On Producing Drug Ingredients Amid Uncertainty Over U.S. Loan
-Dow Jones
Dow Jones · 10/19 18:57
Eastman Kodak CEO Says Company Was 'Understaffed' After U.S. Loan Announced, Declined To Comment On Stats Of Stalled U.S. Loan
-Dow Jone
Dow Jone · 10/19 18:56
Stocks To Watch: GM's Hummer Charges The EV Party, Earnings Blitz
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha, Apple Podcasts, Stitcher and Spotify (click the highlighted links). The earnings season heats up next week, with high-fliers Netflix (NFLX), Tesla (TSLA) and Chipotle (CMG) all reporting. Coming off the heels of a strong retail sales report, economic reports of interest in the week ahead include looks at the
Seekingalpha · 10/17 11:51
3 Stocks I'll Hold Forever · 10/15 07:01
Eastman Kodak and Bloom Energy among industrial gainers; ShiftPixy leads the losers
Gainers: India Globalization Capital (IGC) +29%. Mesa Air Group (MESA) +15%. Matson (MATX) +15%. Eastman Kodak (KODK) +14%. Bloom Energy (BE) +12%.Losers: ShiftPixy (PIXY) -25%. Pioneer Power Solutions (PPSI) -12%. CVD Equipment (CVV) -10%.
Seekingalpha · 10/09 17:01
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of KODK. Analyze the recent business situations of Eastman Kodak through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Institutional Holdings
Institutions: 100
Institutional Holdings: 30.79M
% Owned: 40.78%
Shares Outstanding: 75.49M
Sold Out
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Household Electronics
Computers, Phones & Household Electronics
Key Executives
James Continenza
Chief Financial Officer/Senior Vice President
David Bullwinkle
Senior Vice President/Chief Technology Officer
Terry Taber
Senior Vice President/General Counsel/Secretary
Roger Byrd
Senior Vice President
John O'Grady
Senior Vice President
Randy Vandagriff
Chief Accounting Officer/Controller
Eric Samuels
Independent Director
Richard Bradley
Independent Director
Jeffrey Engelberg
Independent Director
George Karfunkel
Independent Director
Philippe Katz
Independent Director
Jason New
Independent Director
William Parrett
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About KODK
Eastman Kodak Company is a global commercial printing and imaging company with technologies in materials science, digital imaging science and software, and deposition processes. The Company provides hardware, software, consumables and services to customers in graphic arts, commercial print, publishing, packaging, electronic displays, entertainment and commercial films, and consumer products markets. The Company operates through seven segments: Print Systems, Micro 3D Printing and Packaging, Software and Solutions, Consumer and Film, Enterprise Inkjet Systems, Advanced Materials and 3D Printing Technology and Eastman Business Park. The Print Systems segment comprises two lines of business: Prepress Solutions and Electrophotographic Printing Solutions. The Micro 3D Printing and Packaging segment comprises two lines of business: Packaging and Micro 3D Printing.
Hot Stocks

Webull offers kinds of Eastman Kodak Company stock information, including NYSE:KODK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KODK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading KODK stock methods without spending real money on the virtual paper trading platform.